サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1766392

内視鏡止血器具市場、規模、シェア、産業分析レポート：製品別、最終用途別、地域別、2025年～2034年の市場予測

Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
内視鏡止血器具市場、規模、シェア、産業分析レポート：製品別、最終用途別、地域別、2025年～2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、内視鏡止血器具市場規模は2034年までに29億5,480万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

内視鏡止血器具は、内視鏡処置中の活発な消化管出血を制御するために設計された低侵襲器具と定義されます。精密ベースの治療に対する需要が高まる中、この器具の関連性が高まっています。器具の小型化と操作性の向上への移行により、到達困難な出血部位へのアクセスが可能になり、臨床成績が向上しています。これらの進歩により、内視鏡医は患者の不快感を軽減し、回復時間を短縮しながら、より的を絞ったインターベンションを実施できるようになっています。コンパクトで使いやすい医療機器の統合は、ヘルスケアプロバイダーが手技の効率化を求める中で戦略的優先事項となっており、臨床現場での採用がさらに強化されています。

クリッピング、凝固、注射の各機能を1つのシステムに統合することで、多機能技術が1つの機器に統合され、成長機会がさらに促進されます。このような機能の統合により、処置時間が短縮され、機器交換の必要性も最小化されるため、重要な介入時のワークフローと安全性が向上します。さらに、価値ベースのケアモデルへのシフトは、高い水準の臨床効果を維持しながらコスト効率を改善できる多用途ツールの採用を促しています。これらの動向は、内視鏡出血管理の展望を再定義し、現代の消化器診療の進化するニーズと技術革新を一致させています。

内視鏡止血器具市場レポートハイライト

製品別では、結紮クリップが臨床的有効性、使いやすさ、消化管出血管理への幅広い採用で支持され、2024年の市場をリードしました。

エンドユース別では、低侵襲技術やコスト効率の高いヘルスケアソリューションへのシフトにより、外来患者向け分野が最も急成長すると予測されます。

2024年には、北米が最大の収益シェアを占め、先進ヘルスケアシステム、低侵襲手技の高い採用率、主要機器メーカーに支えられています。

アジア太平洋地域の内視鏡止血器具市場は、消化器系疾患の増加、内視鏡治療に対する認知度の向上、ヘルスケアインフラの改善に後押しされ、急成長が見込まれています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の内視鏡止血器具市場の洞察

  • 市場スナップショット
  • 内視鏡止血器具市場力学
    • 促進要因と機会
      • 消化器疾患の有病率の上昇
      • 進歩と製品革新の増大
    • 抑制要因と課題
      • デバイスの高コスト
  • PESTEL分析
  • 内視鏡止血器具の市場動向
  • バリューチェーン分析

第5章 世界の内視鏡止血器具市場：製品別

  • 主な調査結果
  • イントロダクション
  • 結紮クリップ
  • 結紮バンド
  • 注射針
  • 止血スプレー
  • サーマルプローブ
  • アルゴンプラズマ凝固法（APC）
  • 高周波アブレーション（RFA）

第6章 世界の内視鏡止血器具市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 外来施設

第7章 世界の内視鏡止血器具市場：地域別

  • 主な調査結果
  • イントロダクション
    • 内視鏡止血器具市場分析：地域、2020年～2034年
  • 北米
    • 北米：製品別、2020～2034年
    • 北米：最終用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2020～2034年
    • 欧州：最終用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：製品別、2020～2034年
    • アジア太平洋地域：最終用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2020～2034年
    • 中東・アフリカ：最終用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2020～2034年
    • ラテンアメリカ：最終用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Ambu A/S
  • Boston Scientific Corporation
  • CONMED Corporation.
  • Cook Medical Inc.
  • FUJIFILM India Private Limited
  • HOYA Corporation.（PENTAX Medical）
  • Johnson & Johnson
  • KARL STORZ
  • Medtronic
  • MICRO-TECH（Nanjing）Co., Ltd.
  • Olympus America Inc.
  • Richard Wolf GmbH.
  • Smith+Nephew
  • STERIS
  • Stryker
図表

List of Tables:

  • Table 1 Global Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 2 Global Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 3 North America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 4 North America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 5 US: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 6 US: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 7 Canada: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 8 Canada: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 9 Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 10 Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 11 UK: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 12 UK: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 13 France: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 14 France: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 15 Germany: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 16 Germany: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Italy: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 18 Italy: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 19 Spain: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 20 Spain: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 21 Netherlands: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 22 Netherlands: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 23 Russia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 24 Russia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 29 China: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 30 China: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 31 India: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 32 India: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Malaysia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 34 Malaysia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 35 Japan: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 36 Japan: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Indonesia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 38 Indonesia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 39 South Korea: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 40 South Korea: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Australia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 42 Australia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 49 UAE: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 50 UAE: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 51 Israel: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 52 Israel: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 53 South Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 54 South Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 57 Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 58 Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 59 Mexico: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 60 Mexico: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 61 Brazil: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 62 Brazil: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 63 Argentina: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 64 Argentina: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Endoscopic Hemostasis Devices Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Endoscopic Hemostasis Devices Market, by Product, 2024 & 2034 (USD Million)
  • Figure 8. Market by End Use
  • Figure 9. Global Endoscopic Hemostasis Devices Market, by End Use, 2024 & 2034 (USD Million)
目次
Product Code: PM5753

The endoscopic hemostasis devices market size is expected to reach USD 2,954.80 million by 2034, according to a new study by Polaris Market Research. The report "Endoscopic Hemostasis Devices Market Size, Share, & Industry Analysis Report: By Product, By End Use (Hospitals and Outpatient Facilities), and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Endoscopic hemostasis devices are defined as minimally invasive instruments designed to control active gastrointestinal bleeding during endoscopies procedures. The devices are witnessing increased relevance amid the growing demand for precision-based therapeutics. The transition toward device miniaturization and improved maneuverability allows for greater access to difficult-to-reach bleeding sites with improved clinical outcomes. These advancements are allowing endoscopists to perform more targeted interventions with reduced patient discomfort and faster recovery times. The integration of compact, user-friendly medical devices has become a strategic priority as healthcare providers seek to improve procedural efficiency, further reinforcing their adoption across clinical settings.

The integration of multifunctional technologies within single devices, combining clipping, coagulation, and injection capabilities into one system, further propels growth opportunities. This convergence of functionalities reduces procedural time and also minimizes the need for device exchange, improving workflow and safety during critical interventions. Additionally, the shift toward value-based care models is encouraging the adoption of versatile tools that can improve cost-efficiency while maintaining high standards of clinical effectiveness. Together, these trends are redefining the landscape of endoscopic bleeding management, aligning innovation with the evolving needs of the modern gastroenterological practice.

Endoscopic Hemostasis Devices Market Report Highlights

In terms of product, the ligation clips segment led the market in 2024, favored for their clinical efficacy, ease of use, and broad adoption in gastrointestinal bleeding management.

Based on end use, the outpatient segment is anticipated to grow the fastest, driven by the shift toward minimally invasive techniques and cost-efficient healthcare solutions.

In 2024, North America held the largest revenue share, supported by advanced healthcare systems, high adoption of minimally invasive procedures, and leading device manufacturers.

The Asia Pacific endoscopic hemostasis devices market is expected to grow the fastest, propelled by increasing GI disorder prevalence, greater awareness of endoscopic treatments, and improving healthcare infrastructure.

A few global key market players include Ambu A/S; Boston Scientific Corporation; CONMED Corporation; Cook Medical Inc.; FUJIFILM India Private Limited; HOYA Corporation (PENTAX Medical); Johnson & Johnson; KARL STORZ; Medtronic; MICRO-TECH (Nanjing) Co., Ltd.; Olympus America Inc.; Richard Wolf GmbH; Smith+Nephew; STERIS; and Stryker.

Polaris Market Research has segmented the endoscopic hemostasis devices market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Million, 2020-2034)

Ligation Clips

Ligation Bands

Hemorrhoidal

Esophageal

Injection Needles

Hemostatic Spray

Thermal Probes

Contact Probes

Noncontact Probes

Argon Plasma Coagulation (APC)

Radiofrequency Ablation (RFA)

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Outpatient Facilities

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Endoscopic Hemostasis Devices Market Insights

  • 4.1. Endoscopic Hemostasis Devices Market - Market Snapshot
  • 4.2. Endoscopic Hemostasis Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Gastrointestinal Disorders
      • 4.2.1.2. Increasing Advancements and Product Innovation
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Devices
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Endoscopic Hemostasis Devices Market Trends
  • 4.6. Value Chain Analysis

5. Global Endoscopic Hemostasis Devices Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
  • 5.3. Ligation Clips
    • 5.3.1. Global Endoscopic Hemostasis Devices Market, by Ligation Clips, by Region, 2020-2034 (USD Million)
  • 5.4. Ligation Bands
    • 5.4.1. Global Endoscopic Hemostasis Devices Market, by Ligation Bands, by Region, 2020-2034 (USD Million)
    • 5.4.2. Hemorrhoidal
      • 5.4.2.1. Global Endoscopic Hemostasis Devices Market, by Hemorrhoidal, by Region, 2020-2034 (USD Million)
    • 5.4.3. Esophageal
      • 5.4.3.1. Global Endoscopic Hemostasis Devices Market, by Esophageal, by Region, 2020-2034 (USD Million)
  • 5.5. Injection Needles
    • 5.5.1. Global Endoscopic Hemostasis Devices Market, by Injection Needles, by Region, 2020-2034 (USD Million)
  • 5.6. Hemostatic Spray
    • 5.6.1. Global Endoscopic Hemostasis Devices Market, by Hemostatic Spray, by Region, 2020-2034 (USD Million)
  • 5.7. Thermal Probes
    • 5.7.1. Global Endoscopic Hemostasis Devices Market, by Thermal Probes, by Region, 2020-2034 (USD Million)
    • 5.7.2. Contact Probes
      • 5.7.2.1. Global Endoscopic Hemostasis Devices Market, by Contact Probes, by Region, 2020-2034 (USD Million)
    • 5.7.3. Noncontact Probes
      • 5.7.3.1. Global Endoscopic Hemostasis Devices Market, by Noncontact Probes, by Region, 2020-2034 (USD Million)
  • 5.8. Argon Plasma Coagulation (APC)
    • 5.8.1. Global Endoscopic Hemostasis Devices Market, by Argon Plasma Coagulation (APC), by Region, 2020-2034 (USD Million)
  • 5.9. Radiofrequency Ablation (RFA)
    • 5.9.1. Global Endoscopic Hemostasis Devices Market, by Radiofrequency Ablation (RFA), by Region, 2020-2034 (USD Million)

6. Global Endoscopic Hemostasis Devices Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Endoscopic Hemostasis Devices Market, by Hospitals, by Region, 2020-2034 (USD Million)
  • 6.4. Outpatient Facilities
    • 6.4.1. Global Endoscopic Hemostasis Devices Market, by Outpatient Facilities, by Region, 2020-2034 (USD Million)

7. Global Endoscopic Hemostasis Devices Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Endoscopic Hemostasis Devices Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Endoscopic Hemostasis Devices Market - North America
    • 7.3.1. North America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
    • 7.3.2. North America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.3.3. Endoscopic Hemostasis Devices Market - US
      • 7.3.3.1. US: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.3.3.2. US: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.3.4. Endoscopic Hemostasis Devices Market - Canada
      • 7.3.4.1. Canada: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • 7.4. Endoscopic Hemostasis Devices Market - Europe
    • 7.4.1. Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
    • 7.4.2. Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.3. Endoscopic Hemostasis Devices Market - UK
      • 7.4.3.1. UK: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.4. Endoscopic Hemostasis Devices Market - France
      • 7.4.4.1. France: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.4.2. France: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.5. Endoscopic Hemostasis Devices Market - Germany
      • 7.4.5.1. Germany: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.6. Endoscopic Hemostasis Devices Market - Italy
      • 7.4.6.1. Italy: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.7. Endoscopic Hemostasis Devices Market - Spain
      • 7.4.7.1. Spain: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.8. Endoscopic Hemostasis Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.9. Endoscopic Hemostasis Devices Market - Russia
      • 7.4.9.1. Russia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.4.10. Endoscopic Hemostasis Devices Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • 7.5. Endoscopic Hemostasis Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.3. Endoscopic Hemostasis Devices Market - China
      • 7.5.3.1. China: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.3.2. China: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.4. Endoscopic Hemostasis Devices Market - India
      • 7.5.4.1. India: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.4.2. India: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.5. Endoscopic Hemostasis Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.6. Endoscopic Hemostasis Devices Market - Japan
      • 7.5.6.1. Japan: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.7. Endoscopic Hemostasis Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.8. Endoscopic Hemostasis Devices Market - South Korea
      • 7.5.8.1. South Korea: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.9. Endoscopic Hemostasis Devices Market - Australia
      • 7.5.9.1. Australia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.5.10. Endoscopic Hemostasis Devices Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • 7.6. Endoscopic Hemostasis Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.6.3. Endoscopic Hemostasis Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.6.4. Endoscopic Hemostasis Devices Market - UAE
      • 7.6.4.1. UAE: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.6.5. Endoscopic Hemostasis Devices Market - Israel
      • 7.6.5.1. Israel: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.6.6. Endoscopic Hemostasis Devices Market - South Africa
      • 7.6.6.1. South Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.6.7. Endoscopic Hemostasis Devices Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
  • 7.7. Endoscopic Hemostasis Devices Market - Latin America
    • 7.7.1. Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.7.3. Endoscopic Hemostasis Devices Market - Mexico
      • 7.7.3.1. Mexico: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.7.4. Endoscopic Hemostasis Devices Market - Brazil
      • 7.7.4.1. Brazil: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.7.5. Endoscopic Hemostasis Devices Market - Argentina
      • 7.7.5.1. Argentina: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)
    • 7.7.6. Endoscopic Hemostasis Devices Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Endoscopic Hemostasis Devices Market, by Product, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Endoscopic Hemostasis Devices Market, by End Use, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Ambu A/S
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. CONMED Corporation.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Cook Medical Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. FUJIFILM India Private Limited
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. HOYA Corporation. (PENTAX Medical)
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Johnson & Johnson
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. KARL STORZ
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Medtronic
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. MICRO-TECH (Nanjing) Co., Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Olympus America Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Richard Wolf GmbH.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Smith+Nephew
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. STERIS
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Stryker
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development